Home

historisch jeans vloot teva investor relations Soepel intern Schrijfmachine

Investor Relations Officer
Investor Relations Officer

TEVA REPORTS RECORD SALES AND NET INCOME IN Q2 • Net Sales reach $1.2  billion, Net Income $230 million, and EPS $0.35 • Sec
TEVA REPORTS RECORD SALES AND NET INCOME IN Q2 • Net Sales reach $1.2 billion, Net Income $230 million, and EPS $0.35 • Sec

IVAX Corporation
IVAX Corporation

Website: www.tevapharm.com For Immediate Release Teva Reports 2007  Financials in XBRL Standard Intended to Facilitate Investor
Website: www.tevapharm.com For Immediate Release Teva Reports 2007 Financials in XBRL Standard Intended to Facilitate Investor

DEF 14A
DEF 14A

Release No 110 10 October 2003 Lundbeck and Teva announce European  submission of rasagiline as a treatment for Parkinson's dis
Release No 110 10 October 2003 Lundbeck and Teva announce European submission of rasagiline as a treatment for Parkinson's dis

Teva Pharmaceutical Industries Ltd. SICOR Inc. Web Site: www.tevapharm.com  www.sicor.com
Teva Pharmaceutical Industries Ltd. SICOR Inc. Web Site: www.tevapharm.com www.sicor.com

Teva Investor Relations by Teva Pharmaceuticals USA, Inc.
Teva Investor Relations by Teva Pharmaceuticals USA, Inc.

Teva buying Cephalon for $6.8 billion - cleveland.com
Teva buying Cephalon for $6.8 billion - cleveland.com

Yael Ashman - Sr. Director, Investor Relations - Teva Pharmaceuticals |  LinkedIn
Yael Ashman - Sr. Director, Investor Relations - Teva Pharmaceuticals | LinkedIn

MedinCell's Partner Teva Today Announced Refiling for Approval of mdc-IRM  and Confirmed Planned Launch in the U.S. in H1 2023
MedinCell's Partner Teva Today Announced Refiling for Approval of mdc-IRM and Confirmed Planned Launch in the U.S. in H1 2023

Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet
Earnings Preview: It's a mixed bag for Teva Pharma in Q3 | AlphaStreet

Ran Meir - SVP - Investor Relations & Corporate Communications - Teva  Pharmaceuticals | LinkedIn
Ran Meir - SVP - Investor Relations & Corporate Communications - Teva Pharmaceuticals | LinkedIn

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2022 Earnings Call  Transcript
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2022 Earnings Call Transcript

Alvotech to Participate in Jefferies Healthcare Conference
Alvotech to Participate in Jefferies Healthcare Conference

DEF 14A
DEF 14A

Teva Pharmaceutical Industries Ltd. Protalix Ltd. Web Site:  www.tevapharm.com Web Site: www.protalix.com
Teva Pharmaceutical Industries Ltd. Protalix Ltd. Web Site: www.tevapharm.com Web Site: www.protalix.com

Teva Announces New Organization Structure and Leadership Changes | Business  Wire
Teva Announces New Organization Structure and Leadership Changes | Business Wire

ex99-2_008.jpg
ex99-2_008.jpg

Shiri Sommer - Investor Relations Manager - MAOZ מעוז | LinkedIn
Shiri Sommer - Investor Relations Manager - MAOZ מעוז | LinkedIn

Website: www.tevapharm.com FOR IMMEDIATE RELEASE TEVA REPORTS FIRST QUARTER  2006 RESULTS Results include IVAX for the first tim
Website: www.tevapharm.com FOR IMMEDIATE RELEASE TEVA REPORTS FIRST QUARTER 2006 RESULTS Results include IVAX for the first tim

Elana Holzman - Head of Investor Relations - ZIM Integrated Shipping  Services | LinkedIn
Elana Holzman - Head of Investor Relations - ZIM Integrated Shipping Services | LinkedIn